Dynamic procalcitonin-guided antibiotic stewardship among cancer patients in the UK
Journal of Medical Microbiology · 07.04.2026 · 75 (4)
DOI: 10.1099/jmm.0.002145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 07.04.2026. Verfasst von Dowan Kwon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK. Hauptthemen laut MEDLINE: Procalcitonin, Antimicrobial Stewardship, Neoplasms, Anti-Bacterial Agents. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Procalcitonin has been recognized as a tool for effective antibiotic stewardship to reduce unnecessary antibiotic use; however, its effectiveness remains unknown in the oncology setting, where infections are common and antibiotics are frequently prescribed. Gap statement. The utility of procalcitonin for effective antibiotic stewardship in people with solid organ cancers is unknown.
Aim
To evaluate the role of procalcitonin dynamics in solid organ cancer patients with suspected bacterial infections in predicting clinical outcomes and guiding antibiotic therapy decisions. Methodology. A single-centre evaluation was conducted at the Bristol Haematology and Oncology Centre, studying consecutive admissions of adult patients with solid organ cancer over a 3-month period. In a population in which serum procalcitonin levels were sporadically measured to guide antibiotic therapy, they were measured as standard care on admission and at 48 hours for patients admitted with a suspected bacterial infection. A threshold of 0.25 ng ml −1 was used to distinguish between low and high procalcitonin levels. Cases that had persistently low procalcitonin levels were retrospectively analysed for the potential identification of patients who could have had their antibiotic treatment ceased 48 hours into the antibiotic course.
Results
Seventy-seven cases with procalcitonin readings were recorded. Seventy (90.9%) cases received intravenous antibiotics during admission. Twenty-seven (35.1%) cases had persistently low procalcitonin, defined as
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
- Bristol Haematology and Oncology Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Zitieren
APA
Kwon, D., Williams, P., & Winter, H. (2026). Dynamic procalcitonin-guided antibiotic stewardship among cancer patients in the UK. Journal of Medical Microbiology, 75(4). https://doi.org/10.1099/jmm.0.002145
Vancouver
Kwon D, Williams P, Winter H. Dynamic procalcitonin-guided antibiotic stewardship among cancer patients in the UK. Journal of Medical Microbiology. 2026;75(4). doi:10.1099/jmm.0.002145
BibTeX
@article{Kwon2026,
author = {Kwon, Dowan and Williams, Philip and Winter, Helen},
title = {Dynamic procalcitonin-guided antibiotic stewardship among cancer patients in the UK},
journal = {Journal of Medical Microbiology},
year = {2026},
volume = {75},
number = {4},
doi = {10.1099/jmm.0.002145}
}
EUVIMED